1 Hepatitis Drugs Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Hepatitis Drugs 1.3 Hepatitis Drugs Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Hepatitis Drugs Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Hepatitis Drugs 1.4.2 Applications of Hepatitis Drugs 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Hepatitis Drugs Analysis 2.2 Major Players of Hepatitis Drugs 2.2.1 Major Players Manufacturing Base and Market Share of Hepatitis Drugs in 2018 2.2.2 Major Players Product Types in 2018 2.3 Hepatitis Drugs Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Hepatitis Drugs 2.3.3 Raw Material Cost of Hepatitis Drugs 2.3.4 Labor Cost of Hepatitis Drugs 2.4 Market Channel Analysis of Hepatitis Drugs 2.5 Major Downstream Buyers of Hepatitis Drugs Analysis 3 Europe Hepatitis Drugs Market, by Type 3.1 Europe Hepatitis Drugs Value and Market Share by Type (2014-2019E) 3.2 Europe Hepatitis Drugs Consumption and Market Share by Type (2014-2019E) 3.3 Europe Hepatitis Drugs Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Hepatitis Drugs Value and Growth Rate of Oral 3.3.2 Europe Hepatitis Drugs Value and Growth Rate of Injection 3.4 Europe Hepatitis Drugs Price Analysis by Type (2014-2019E) 4 Hepatitis Drugs Market, by Application 4.1 Downstream Market Overview 4.2 Europe Hepatitis Drugs Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Hepatitis Drugs Consumption and Growth Rate of Hospital (2014-2019E) 4.2.2 Europe Hepatitis Drugs Consumption and Growth Rate of Clinic (2014-2019E) 5 Europe Hepatitis Drugs Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Hepatitis Drugs Value and Market Share by Countries (2014-2019E) 5.2 Europe Hepatitis Drugs Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 F. Hoffmann-La Roche 6.2.1 Company Profiles 6.2.2 Hepatitis Drugs Product Introduction 6.2.3 F. Hoffmann-La Roche Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 F. Hoffmann-La Roche Market Share of Hepatitis Drugs Segmented by Region in 2018 6.3 GlaxoSmithKline 6.3.1 Company Profiles 6.3.2 Hepatitis Drugs Product Introduction 6.3.3 GlaxoSmithKline Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 GlaxoSmithKline Market Share of Hepatitis Drugs Segmented by Region in 2018 6.4 Abbvie 6.4.1 Company Profiles 6.4.2 Hepatitis Drugs Product Introduction 6.4.3 Abbvie Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 Abbvie Market Share of Hepatitis Drugs Segmented by Region in 2018 6.5 Mitsubishi Tanabe Pharma 6.5.1 Company Profiles 6.5.2 Hepatitis Drugs Product Introduction 6.5.3 Mitsubishi Tanabe Pharma Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 Mitsubishi Tanabe Pharma Market Share of Hepatitis Drugs Segmented by Region in 2018 6.6 Dynavax Technologies 6.6.1 Company Profiles 6.6.2 Hepatitis Drugs Product Introduction 6.6.3 Dynavax Technologies Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 Dynavax Technologies Market Share of Hepatitis Drugs Segmented by Region in 2018 6.7 Bristol-Myers Squibb 6.7.1 Company Profiles 6.7.2 Hepatitis Drugs Product Introduction 6.7.3 Bristol-Myers Squibb Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Bristol-Myers Squibb Market Share of Hepatitis Drugs Segmented by Region in 2018 6.8 Achillion Pharmaceuticals 6.8.1 Company Profiles 6.8.2 Hepatitis Drugs Product Introduction 6.8.3 Achillion Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 Achillion Pharmaceuticals Market Share of Hepatitis Drugs Segmented by Region in 2018 6.9 Vertex Pharmaceuticals 6.9.1 Company Profiles 6.9.2 Hepatitis Drugs Product Introduction 6.9.3 Vertex Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Vertex Pharmaceuticals Market Share of Hepatitis Drugs Segmented by Region in 2018 6.10 Johnson & Johnson 6.10.1 Company Profiles 6.10.2 Hepatitis Drugs Product Introduction 6.10.3 Johnson & Johnson Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 Johnson & Johnson Market Share of Hepatitis Drugs Segmented by Region in 2018 6.11 Gilead Sciences 6.11.1 Company Profiles 6.11.2 Hepatitis Drugs Product Introduction 6.11.3 Gilead Sciences Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 Gilead Sciences Market Share of Hepatitis Drugs Segmented by Region in 2018 6.12 Merck 6.12.1 Company Profiles 6.12.2 Hepatitis Drugs Product Introduction 6.12.3 Merck Sales, Value, Price, Gross Margin 2014-2019E 6.12.4 Merck Market Share of Hepatitis Drugs Segmented by Region in 2018 6.13 Novartis 6.13.1 Company Profiles 6.13.2 Hepatitis Drugs Product Introduction 6.13.3 Novartis Sales, Value, Price, Gross Margin 2014-2019E 6.13.4 Novartis Market Share of Hepatitis Drugs Segmented by Region in 2018 7 Europe Hepatitis Drugs Market Analysis and Forecast by Type and Application 7.1 Europe Hepatitis Drugs Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 Oral Market Value and Volume Forecast (2019-2024) 7.1.2 Injection Market Value and Volume Forecast (2019-2024) 7.2 Europe Hepatitis Drugs Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 Hospital Market Value and Volume Forecast (2019-2024) 7.2.2 Clinic Market Value and Volume Forecast (2019-2024) 8 Hepatitis Drugs Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source

List of Tables and Figures Figure Product Picture of Hepatitis Drugs Table Product Specification of Hepatitis Drugs Figure Market Concentration Ratio and Market Maturity Analysis of Hepatitis Drugs Figure Europe Hepatitis Drugs Value ($) and Growth Rate from 2014-2024 Table Different Types of Hepatitis Drugs Figure Europe Hepatitis Drugs Value ($) Segment by Type from 2014-2019E Figure Europe Hepatitis Drugs Market Share by Types in 2018 Figure Oral Picture Figure Injection Picture Table Different Applications of Hepatitis Drugs Figure Europe Hepatitis Drugs Value ($) Segment by Applications from 2014-2019E Figure Europe Hepatitis Drugs Market Share by Applications in 2018 Figure Hospital Picture Figure Clinic Picture Table Research Countries of Hepatitis Drugs Figure Europe Hepatitis Drugs Market Share by Countries in 2018 Figure Germany Hepatitis Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Hepatitis Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure France Hepatitis Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Hepatitis Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Hepatitis Drugs Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Hepatitis Drugs Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Hepatitis Drugs Table Industry News Table Industry Policies Figure Industry Chain Analysis of Hepatitis Drugs Table Upstream Raw Material Suppliers of Hepatitis Drugs with Contact Information Table Major Players Manufacturing Base and Market Share of Hepatitis Drugs in 2018 Table Major Players Consumption Value Market Share of Hepatitis Drugs in 2018 Table Major Players Hepatitis Drugs Product Types in 2018 Figure Consumption Process of Hepatitis Drugs Figure Manufacturing Cost Structure of Hepatitis Drugs Figure Channel Status of Hepatitis Drugs Table Major Distributors of Hepatitis Drugs with Contact Information Table Major Downstream Buyers of Hepatitis Drugs with Contact Information Table Europe Hepatitis Drugs Value ($) by Type (2014-2019E) Table Europe Hepatitis Drugs Value Share by Type (2014-2019E) Figure Europe Hepatitis Drugs Value Share by Type (2014-2019E) Table Europe Hepatitis Drugs Consumption by Type (2014-2019E) Table Europe Hepatitis Drugs Consumption Share by Type (2014-2019E) Figure Europe Hepatitis Drugs Consumption Share by Type (2014-2019E) Figure Oral Picture Figure Injection Picture Figure Europe Hepatitis Drugs Value ($) and Growth Rate of Injection Table Europe Hepatitis Drugs Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Hepatitis Drugs Consumption by Application (2014-2019E) Table Europe Hepatitis Drugs Consumption Market Share by Application (2014-2019E) Figure Europe Hepatitis Drugs Consumption Market Share by Application (2014-2019E) Figure Europe Hepatitis Drugs Consumption and Growth Rate of Hospital (2014-2019) Figure Europe Hepatitis Drugs Consumption and Growth Rate of Clinic (2014-2019) Table Europe Hepatitis Drugs Value ($) by Countries (2014-2019E) Table Europe Hepatitis Drugs Value Market Share by Countries (2014-2019E) Figure Europe Hepatitis Drugs Value Market Share by Countries (2014-2019E) Table Europe Hepatitis Drugs Consumption by Countries (2014-2019E) Table Europe Hepatitis Drugs Consumption Market Share by Countries (2014-2019E) Figure Europe Hepatitis Drugs Consumption Market Share by Countries (2014-2019E) Table Europe Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table France Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Hepatitis Drugs Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Hepatitis Drugs Companies in 2018 Figure Top 6 Market Share of Hepatitis Drugs Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table F. Hoffmann-La Roche Sales, Value, Price, Gross Margin 2014-2019E Figure F. Hoffmann-La Roche Sales and Growth Rate Figure F. Hoffmann-La Roche Value ($) Market Share 2014-2019 Figure F. Hoffmann-La Roche Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table GlaxoSmithKline Sales, Value, Price, Gross Margin 2014-2019E Figure GlaxoSmithKline Sales and Growth Rate Figure GlaxoSmithKline Value ($) Market Share 2014-2019 Figure GlaxoSmithKline Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Abbvie Sales, Value, Price, Gross Margin 2014-2019E Figure Abbvie Sales and Growth Rate Figure Abbvie Value ($) Market Share 2014-2019 Figure Abbvie Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Mitsubishi Tanabe Pharma Sales, Value, Price, Gross Margin 2014-2019E Figure Mitsubishi Tanabe Pharma Sales and Growth Rate Figure Mitsubishi Tanabe Pharma Value ($) Market Share 2014-2019 Figure Mitsubishi Tanabe Pharma Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Dynavax Technologies Sales, Value, Price, Gross Margin 2014-2019E Figure Dynavax Technologies Sales and Growth Rate Figure Dynavax Technologies Value ($) Market Share 2014-2019 Figure Dynavax Technologies Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Bristol-Myers Squibb Sales, Value, Price, Gross Margin 2014-2019E Figure Bristol-Myers Squibb Sales and Growth Rate Figure Bristol-Myers Squibb Value ($) Market Share 2014-2019 Figure Bristol-Myers Squibb Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Achillion Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E Figure Achillion Pharmaceuticals Sales and Growth Rate Figure Achillion Pharmaceuticals Value ($) Market Share 2014-2019 Figure Achillion Pharmaceuticals Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Vertex Pharmaceuticals Sales, Value, Price, Gross Margin 2014-2019E Figure Vertex Pharmaceuticals Sales and Growth Rate Figure Vertex Pharmaceuticals Value ($) Market Share 2014-2019 Figure Vertex Pharmaceuticals Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Johnson & Johnson Sales, Value, Price, Gross Margin 2014-2019E Figure Johnson & Johnson Sales and Growth Rate Figure Johnson & Johnson Value ($) Market Share 2014-2019 Figure Johnson & Johnson Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Gilead Sciences Sales, Value, Price, Gross Margin 2014-2019E Figure Gilead Sciences Sales and Growth Rate Figure Gilead Sciences Value ($) Market Share 2014-2019 Figure Gilead Sciences Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Merck Sales, Value, Price, Gross Margin 2014-2019E Figure Merck Sales and Growth Rate Figure Merck Value ($) Market Share 2014-2019 Figure Merck Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Novartis Sales, Value, Price, Gross Margin 2014-2019E Figure Novartis Sales and Growth Rate Figure Novartis Value ($) Market Share 2014-2019 Figure Novartis Market Share of Hepatitis Drugs Segmented by Region in 2018 Table Europe Hepatitis Drugs Market Value ($) Forecast, by Type Table Europe Hepatitis Drugs Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery